ClinicalTrials.govpublic full text
Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
acute coronary syndrome, chronic kidney disease, end-stage renal disease, egfr, ticagrelor, clopidogrel, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900068
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.